Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUN PHARMA Quarterly Results  (SUNP)



Here are the latest quarterly results of SUN PHARMA. For more details, see the SUN PHARMA financial fact sheet and SUN PHARMA share price. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

SUN PHARMA Quarterly Results

No. of Mths
Qtr. Ending
3
Mar-22
*
3
Jun-22
*
3
Sep-22
*
3
Dec-22
*
3
Mar-23
*
3
Jun-23
*
3
Sep-23
*
3
Dec-23
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m94,468107,618109,523112,410109,307119,408121,924123,807 
Other income Rs m2,7461,4788521,7393,7332,0652,9363,748 
Turnover Rs m97,214109,096110,375114,149113,040121,473124,860127,555 
Expenses Rs m72,67480,23079,95782,37381,28586,11190,13090,284 
Gross profit Rs m-17,56427,38729,56630,03726,30730,06931,79432,825 
Depreciation Rs m5,5655,8806,1006,6006,7156,5136,3286,221 
Interest Rs m373137194462927809493347 
Profit before tax Rs m-20,75622,84824,12424,71522,39724,81127,90930,004 
Tax Rs m1,4681,8901,5232,8342,2294,6813,9014,323 
Profit after tax Rs m-22,22420,95922,60221,88020,16820,13024,00825,680 
Gross profit margin %-18.625.427.026.724.125.226.126.5 
Effective tax rate %-7.18.36.311.510.018.914.014.4 
Net profit margin %-23.519.520.619.518.516.919.720.7 
Diluted EPS Rs -9.3 8.7 9.4 9.1 8.4 8.4 10.0 10.7  
Diluted EPS (TTM) Rs 14.2 17.1 17.8 18.0 35.7 35.3 35.9 37.5  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Today's Market

Sensex Today Trades Lower | Asian Paints Plunges 4% | Wipro & Titan Top Losers Sensex Today Trades Lower | Asian Paints Plunges 4% | Wipro & Titan Top Losers(10:30 am)

Asian stocks were taking a breather near seven-month highs on Monday as investors awaited inflation data from the United States, Japan and Europe that will help refine expectations for future rate moves.